Profile picture for user andreich
Andrei Chirileasa
Editor-in-Chief

Andrei studied finance at the Bucharest Academy of Economic Studies and started his journalism career in 2004 with Ziarul Financiar, the leading financial newspaper in Romania, where he worked for ten years, the last six of which as editor of the capital markets section. He joined the Romania-Insider.com team in 2014 as editor and became Editor-in-Chief in 2016. He currently oversees the daily content published on Romania-Insider.com and likes to stay up to date with everything relevant in business, politics, and life in Romania. Andrei lives with his family in the countryside in Northern Romania, where he built their own house. In his free time, he studies horticulture and tends to his family’s garden. He enjoys foraging in the woods and long walks on the hills and valleys around his village. Email him for story ideas and interviews at andrei@romania-insider.com. 

 

Biggest pharmaceutical group in Romania sees 20% production increase in first half

Zentiva Romania, the biggest pharmaceutical producer in the country, reported a consolidated turnover of RON 514 mln (EUR 104 mln) in the first half of this year and said its local factories increased their production by 20% compared with the same period of 2020.

The Zentiva factory recorded a net turnover of RON 330 mln in the first half of this year, up by 17% compared with the first six months of 2020.

However, its net profit went down by 17% to RON 34.6 mln due to the faster rise in operating expenses, according to a report posted on the Bucharest Stock Exchange.

The group’s second local business, Labormed Pharma Trading, increased its sales by 22% year-on-year.

The group’s best-selling product is the pain killer paracetamol, for which Zentiva recorded higher domestic demand as well as exports, due to new contracts on the German market.

(Photo courtesy of the company)

andrei@romania-insider.com

Normal
Profile picture for user andreich
Andrei Chirileasa
Editor-in-Chief

Andrei studied finance at the Bucharest Academy of Economic Studies and started his journalism career in 2004 with Ziarul Financiar, the leading financial newspaper in Romania, where he worked for ten years, the last six of which as editor of the capital markets section. He joined the Romania-Insider.com team in 2014 as editor and became Editor-in-Chief in 2016. He currently oversees the daily content published on Romania-Insider.com and likes to stay up to date with everything relevant in business, politics, and life in Romania. Andrei lives with his family in the countryside in Northern Romania, where he built their own house. In his free time, he studies horticulture and tends to his family’s garden. He enjoys foraging in the woods and long walks on the hills and valleys around his village. Email him for story ideas and interviews at andrei@romania-insider.com. 

 

Biggest pharmaceutical group in Romania sees 20% production increase in first half

Zentiva Romania, the biggest pharmaceutical producer in the country, reported a consolidated turnover of RON 514 mln (EUR 104 mln) in the first half of this year and said its local factories increased their production by 20% compared with the same period of 2020.

The Zentiva factory recorded a net turnover of RON 330 mln in the first half of this year, up by 17% compared with the first six months of 2020.

However, its net profit went down by 17% to RON 34.6 mln due to the faster rise in operating expenses, according to a report posted on the Bucharest Stock Exchange.

The group’s second local business, Labormed Pharma Trading, increased its sales by 22% year-on-year.

The group’s best-selling product is the pain killer paracetamol, for which Zentiva recorded higher domestic demand as well as exports, due to new contracts on the German market.

(Photo courtesy of the company)

andrei@romania-insider.com

Normal
 

facebooktwitterlinkedin

1

Romania Insider Free Newsletters